Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome in Mozambique
Author Information
Author(s): Letang Emilio, Miró José M., Nhampossa Tacilta, Ayala Edgar, Gascon Joaquim, Menéndez Clara, Alonso Pedro L., Naniche Denise
Primary Institution: Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Maputo, Mozambique
Hypothesis
What are the incidence and predictors of Immune Reconstitution Inflammatory Syndrome (IRIS) in rural Mozambique?
Conclusion
IRIS is common in patients initiating ART in rural Mozambique, and pre-ART CD4 counts and BMI can help identify those at high risk.
Supporting Evidence
- Thirty-six patients developed IRIS, representing an incidence rate of 3.1 cases per 100 persons-month of ART.
- Pre-ART CD4 count <50 cells/µl and BMI <18.5 were identified as independent predictors of IRIS.
- All patients continued ART, with 19.4% requiring hospitalization due to IRIS.
Takeaway
When people start HIV treatment, some can get worse instead of better because their immune system is reacting strongly. This study found that checking certain health markers can help doctors know who might have this problem.
Methodology
A prospective observational cohort study followed 136 ART-naïve HIV-1-infected patients for 16 months to assess IRIS incidence and predictors.
Potential Biases
Potential bias due to the passive case-finding approach and reliance on clinical definitions of IRIS.
Limitations
The study may have overestimated IRIS incidence due to passive case-finding and lacked confirmatory diagnostic tests.
Participant Demographics
All participants were HIV-1 positive adults, predominantly female (58.8%), with a median age of 36 years.
Statistical Information
P-Value
0.01
Confidence Interval
95% CI 1.19–4.44
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website